‘safer use of intravenous gentamicin for neonates’ how-to guide
TRANSCRIPT
![Page 1: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/1.jpg)
‘Safer use of intravenous gentamicin for neonates’ how-to guide
![Page 2: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/2.jpg)
Why do we need an alert?
• Used in 89 per cent of neonatal units• Over 500 patient safety incidents reported to NPSA
in 2008/2009• Side effects include vestibular and auditory
damage, and nephrotoxicity• Narrow therapeutic range necessitates regular
monitoring of blood serum concentrations
![Page 3: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/3.jpg)
Gentamicin pharmokinetic informationGentamicin is a broad spectrum aminoglycoside antibiotic which is widely used in the treatment of neonatal infection. It is not absorbed intestinally and therefore is given by injection. It is associated with a risk of kidney damage and hearing impairment. Adverse effects are particularly associated with patients with poor renal function and where higher gentamicin blood levels and longer duration of therapy have been used.
![Page 4: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/4.jpg)
Background to alert development
PS
A
Neonatal Nurses Association
![Page 5: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/5.jpg)
What does the alert say?
![Page 6: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/6.jpg)
Develop a local gentamicin protocol
• A local protocol is available that clarifies:• The initial dose and frequency of
administration• Blood level monitoring requirements• Arrangements for subsequent dosing
adjustments based on blood levels taken
![Page 7: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/7.jpg)
Ensure local policies include bundle
Local protocol
Use care bundle
PDSA cycle
Measurement
Training
•24-hour clock format should be used when prescribing
•Unused time slots in prescription administration record should be blocked out at time of dosing to prevent wrong time dosing
•Interruptions during the preparation and administration of gentamicin should be minimised by the wearing of a disposable coloured apron by staff to indicate that they should not be disturbed
•The prescribed dose of gentamicin should be given within one hour of the prescribed time
•A double-checking prompt should be used during the preparation and administration of gentamicin
24-hour clock Coloured apron
Double-checking
Dose within one hour
![Page 8: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/8.jpg)
Double checking prompt
Local protocol
Use care bundle
PDSA cycle
Measurement
Training
![Page 9: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/9.jpg)
PDSA cycle applied to gentamicin
![Page 10: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/10.jpg)
Add more patients after each cycle
• Start the actions in the alert for one patient and move through the PDSA cycle
• When your run chart shows at least 80 per cent compliance add more patients and start the cycle again
• This process should be repeated from one patient, to three, to five, etc. (this is the 1:3:5 approach)
![Page 11: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/11.jpg)
Three steps to measurement
![Page 12: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/12.jpg)
Complete the compliance chart
Care bundle compliance
chart
Care bundle daily audit
chart
Extranet / run chart
243 128 462701/01/2010 16.07
![Page 13: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/13.jpg)
Complete the compliance chart
Care bundle compliance
chart
Care bundle daily audit
chart
Extranet / run chart
![Page 14: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/14.jpg)
Fill out the audit chart and totals
Care bundle
compliance chart
Care bundle
daily audit chart
Extranet / run chart
![Page 15: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/15.jpg)
Upload audit totals on the extranet
Care bundle compliance
chart
Care bundle daily audit
chart
Extranet / run chart
From the daily audit chart
![Page 16: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/16.jpg)
Upload audit totals on the extranet
Care bundle compliance
chart
Care bundle daily audit
chart
Extranet / run chart
![Page 17: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/17.jpg)
Helpful resources
• In addition to these slides you can also expect the following resources to aid in your implementation:• Instructional Webinar presentations• FAQs published on the website• Resources on PDSA cycles and
measurement from the Patient Safety First and 1000 Lives campaign websites
![Page 18: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/18.jpg)
Therapeutic drug monitoring: why do it?• Prevent drug toxicity• Ensure drug efficacy
![Page 19: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/19.jpg)
Principles of therapeutic drug monitoring
Be sure to follow your local gentamicin policy when progressing through the above principles
![Page 20: ‘Safer use of intravenous gentamicin for neonates’ how-to guide](https://reader030.vdocuments.us/reader030/viewer/2022033022/56649e875503460f94b8b7df/html5/thumbnails/20.jpg)
Support with the measurement extranet• Patient Safety First Office: 020 79279569 or
www.patientsafetyfirst.nhs.uk • 1000 Lives Office (Wales): 029 20827651 or
www.1000livescampaign.wales.nhs.uk or the 1000 Lives Campaign contact for the Health Board